Publications by authors named "Lisa Hampson"

Claim this Profile
C
Clinical trials with interim analyses: standardizing terminology to increase clarity.
Elina Asikanius, Benjamin Hofner, Lisa V Hampson, Gernot Wassmer, Christopher Jennison

Trials· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RMST for Interval-Censored Data in Oncology Clinical Trials.
Xiyuan Gao, Tianmeng Lyu, Menghao Xu, Lisa V Hampson, Yan Du

Stat Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring overall survival in pivotal trials in indolent cancers.
Thomas R Fleming, Lisa V Hampson, Bharani Bharani-Dharan, Frank Bretz, Arunava Chakravartty

Stat Biopharm Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assurance methods for designing a clinical trial with a delayed treatment effect.
James A Salsbury, Jeremy E Oakley, Steven A Julious, Lisa V Hampson

Stat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma.
Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, Evgeny Degtyarev, Lisa V Hampson

J Comp Eff Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case study.
Björn Holzhauer, Lisa V Hampson, John Paul Gosling, Björn Bornkamp, Joseph Kahn

Pharm Stat· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal Trials.
Lisa V Hampson, Björn Holzhauer, Björn Bornkamp, Joseph Kahn, Markus R Lange

Clin Pharmacol Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the assessment of the probability of success in late stage drug development.
Lisa V Hampson, Björn Bornkamp, Björn Holzhauer, Joseph Kahn, Markus R Lange

Pharm Stat· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial.
Paul A Brogan, Barbara Arch, Helen Hickey, Jordi Anton, Este Iglesias, Lisa V Hampson

Arthritis Rheumatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study to evaluate the optimal dose of remifentanil required to ensure apnea during magnetic resonance imaging of the heart under general anesthesia.
Philip Arnold, Syed Sanaulla, Lisa V Hampson, Annette Davis, Jacinth Tan

Paediatr Anaesth· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging across patient subgroups in phase I oncology trials that incorporate animal data.
Haiyan Zheng, Lisa V Hampson, Thomas Jaki

Stat Methods Med Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian decision-theoretic approach to incorporate preclinical information into phase I oncology trials.
Haiyan Zheng, Lisa V Hampson

Biom J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response modelling approaches for determining optimal dosing rules in children.
Ian Wadsworth, Lisa V Hampson, Björn Bornkamp, Thomas Jaki

Stat Methods Med Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.
Nigel Stallard, Lisa Hampson, Norbert Benda, Werner Brannath, Thomas Burnett

Stat Biopharm Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing and evaluating dose-escalation studies made easy: The MoDEsT web app.
Philip Pallmann, Fang Wan, Adrian P Mander, Graham M Wheeler, Christina Yap, Lisa V Hampson

Clin Trials· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust Bayesian meta-analytic approach to incorporate animal data into phase I oncology trials.
Haiyan Zheng, Lisa V Hampson, Simon Wandel

Stat Methods Med Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimands and the Patient Journey: Addressing the Right Question in Oncology Clinical Trials.
Evgeny Degtyarev, Yiyun Zhang, Kapildeb Sen, David Lebwohl, Mouna Akacha, Lisa V Hampson

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.
William Sones, Steven A Julious, Joanne C Rothwell, Craig Robert Ramsay, Lisa V Hampson

Trials· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA five-stage study, including a workshop.
Jonathan A Cook, Steven A Julious, William Sones, Lisa V Hampson, Catherine Hewitt

Health Technol Assess· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating Innovative Techniques Toward Extrapolation and Efficient Pediatric Drug Development.
Margaret Gamalo-Siebers, Lisa Hampson, Kattayoun Kordy, Sebastian Weber, Robert M Nelson

Ther Innov Regul Sci· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873.
Thomas Jaki, Allan Gordon, Pamela Forster, Luc Bijnens, Bjoern Bornkamp, Lisa V Hampson

Pharm Stat· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcome-13/OS2016 trial protocol: a multicentre, randomised, open-label, phase II trial of mifamurtide combined with postoperative chemotherapy for patients with newly diagnosed high-risk osteosarcoma.
Caroline Brard, Sophie Piperno-Neumann, Jessy Delaye, Laurence Brugières, Lisa V Hampson

BMJ Open· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
Caroline Brard, Lisa V Hampson, Nathalie Gaspar, Marie-Cécile Le Deley, Gwénaël Le Teuff

BMC Med Res Methodol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.
Jonathan A Cook, Steven A Julious, William Sones, Lisa V Hampson, Catherine Hewitt

Trials· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.
Jonathan A Cook, Steven A Julious, William Sones, Lisa V Hampson, Catherine Hewitt

BMJ· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis